A comparative study was performed on the ability of IgG and F(abЈ) 2 antivenoms to neutralize lethal and myotoxic activities of Micrurus nigrocinctus venom. Both antivenoms were adjusted to a similar neutralizing potency in experiments where venom and antivenoms were preincubated prior to injection. No significant differences were observed between IgG and F(abЈ) 2 antivenoms concerning neutralization of lethal effect in rescue experiments, i.e., when antivenom was administered intravenously after envenomation. However, F(abЈ) 2 antivenom was more effective in prolonging the time of death when subneutralizing doses were administered immediately after venom injection. Both products partially reversed the binding of M. nigrocinctus ␣-neurotoxins to acetylcholine receptor in vitro. The IgG and F(abЈ) 2 antivenoms effectively neutralized venom-induced myotoxicity when administered intravenously immediately after envenomation, although neutralization was poor if antivenom injections were delayed. Intramuscular injection of venom promoted diffusion of antivenom antibodies throughout muscle tissue, and F(abЈ) 2 diffused to a higher extent than IgG molecules. Thus, despite the observation that F(abЈ) 2 antivenom was more effective than IgG antivenom in prolonging the time of death when subneutralizing doses were administered immediately after envenomation, no major differences were observed in antivenom neutralization of lethal and myotoxic effects or in their capacity to reverse neurotoxin binding to the acetylcholine receptor.
Antivenoms constitute the mainstay for treating snakebites 1 and many antivenoms are currently produced around the world. 2, 3 The majority of these products are made of F(abЈ) 2 antibody fragments resulting from pepsin digestion of equine immunoglobulins, 4 although some manufacturers produce whole IgG antivenoms. 5 Pharmacokinetic studies show that F(abЈ) 2 fragments have a more convenient profile than whole IgG preparations since they have larger volumes of distribution and reach the tissue compartment at a faster rate. 6, 7 Thus, it has been assumed that F(abЈ) 2 antivenoms are more effective than IgG products in reaching and neutralizing toxins within tissues. However, León and others 8 described that IgG and F(abЈ) 2 polyvalent antivenoms do not differ in their ability to neutralize local hemorrhage, edema, and myonecrosis induced by the venom of the crotaline snake Bothrops asper. It is therefore important to test this assumption in a variety of venom-antivenom systems.
Coral snakes (genus Micrurus) are the representatives of the family Elapidae in America, 9 inflicting a number of accidents on this continent. [10] [11] [12] Although poorly studied, Micrurus venoms induce typical neurotoxic effects, with blockade of the neuromuscular synapse by ␣-neurotoxins that bind cholinergic receptors at the motor endplate. [13] [14] [15] Micrurus ␣neurotoxins are similar to those of other elapids. 14, 15 They are low molecular weight proteins that rapidly spread throughout tissues and bind acetylcholine receptor (AchR) with very high affinity. 16 Moreover, Micrurus venoms also contain myotoxic phospholipases A 2 . 14, 15 Therefore, these venoms constitute a useful model to compare the efficacy of IgG and F(abЈ) 2 antivenoms in experiments that resemble an actual envenomation, i.e., when antivenom is administered after venom injection. A comparative analysis of the neutralization of lethal and myotoxic activities of M. nigrocinctus venom by IgG and F(abЈ) 2 antivenoms is presented in this communication.
MATERIALS AND METHODS
Venom and antivenoms. Micrurus nigrocinctus venom was a pool obtained from more than 60 adult specimens collected in different regions of Costa Rica. Venom was lyophilized and stored at Ϫ20ЊC. The median lethal dose (LD 50 ) by intraperitoneal injection was 10 g/16-18 g (ϳ0.59 g/g) in Swiss-Webster mice. Antivenoms were prepared from the same batch of horse hyperimmune plasma following immunization with M. nigrocinctus venom at the Production Division of Instituto Clodomiro Picado. Whole IgG antivenom was prepared by caprylic acid precipitation of plasma. 5 The F(abЈ) 2 antivenom was obtained by pepsin digestion of plasma (1 g of pepsin/100 ml of plasma) at pH 3.0 for 40 min at 20-23ЊC. After filtration through Whatman (Maidstone, United Kingdom) 2V paper, the pH was adjusted to 5.8 and caprylic acid was added to a final concentration of 5% (v/v). 5 After stirring for 1 hr, an additional filtration step was performed and the filtrate was dialyzed against distilled water. The pH was then adjusted to 7.4, and sodium chloride plus phenol were added to give final concentrations of 0.85 g/dl and 0.25 g/dl, respectively. Both IgG and F(abЈ) 2 antivenoms were adjusted to the same neutralizing potency against lethality induced by M. nigrocinctus venom in preincubation-type experiments. Antivenoms were sterilized by filtration through 0.22-m nitrocellulose membranes and dispensed in 10-ml vials. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis run under non-reducing conditions in 10% gels, 17 was used to analyze protein components of antivenoms.
Neutralization studies. Preincubation of venom and antivenoms. Mixtures containing a constant amount of venom and varying dilutions of antivenoms were prepared in phosphate-buffered saline solution (PBS), pH 7.2 and incubated at 37ЊC for 30 min. Aliquots (0.5 ml) of the mixtures containing an amount of venom corresponding to 4 LD 50 s were * Mice were injected intraperitoneally with 20 g of venom (2 median lethal doses), and various volumes of antivenoms were administered intravenously at different time periods after the venom dose. Deaths were recorded over a 72-hr period.
† Results are presented as the 50% effective dose and correspond to the volume of antivenom (l) that protected 50% of envenomated mice. The 95% confidence limits are included in parentheses.
‡ In these cases, the 50% effective dose was not achieved at the highest antivenom dose (200 l).
injected intraperitoneally into groups of four mice (16-18 g) . Deaths were recorded over 72 hr and the 50% effective dose (ED 50 ) was estimated by probit analysis. 18 Neutralization was expressed as micrograms of venom neutralized by 1 ml of antivenom.
Independent injection of venom and antivenoms. Groups of four mice (16-18 g) were injected intraperitoneally with 20 g of venom (corresponding to 2 LD 50 s) dissolved in 0.5 ml of PBS. Various dilutions (0.2 ml) of either IgG or F(abЈ) 2 antivenoms were then administered intravenously at either 0, 10, 20, 30, or 60 min after envenomation. Deaths were recorded over a 72-hr period and ED 50 s were estimated by probit analysis. Besides estimation of ED 50 , the time of death was recorded in experiments in which mice were injected intraperitoneally with 4 LD 50 s of venom and then received various volumes of antivenoms. In this type of experiment, antivenom doses were ineffective in preventing death, but prolonged time of death when compared with animals injected with venom alone.
Reversal of neurotoxin binding to AchR by antivenoms. Acetyl choline receptor was purified from the electric organ of Torpedo californica as described by Alape-Girón and others 19 and antiserum to AchR was prepared by immunizing guinea pigs. To study the ability of IgG and F(abЈ) 2 molecules to reverse the binding of M. nigrocinctus ␣-neurotoxins to AchR, microtiter wells were coated with venom (5 g/ well) and incubated with AchR (5 g/well). 19 After removal of unbound receptor, various amounts of either IgG or F(abЈ) 2 were added to the wells. Antibodies were purified from antivenoms by affinity chromatography on Sepharose coupled with M. nigrocinctus venom. A control IgG was purified by protein G-affinity chromatography from the serum of horses not immunized with venom. After a 30 min incubation at room temperature and a washing step, guinea pig anti-AchR serum was added, followed by anti-guinea pig IgG conjugated to alkaline phosphatase (Sigma, St. Louis, MO) and p-nitrophenyl phosphate substrate solution. Absorbances were recorded at 405 nm and results are presented as a percentage of binding reversal, relative to the absorbances of wells incubated in parallel with control IgG.
Neutralization of myotoxicity. Groups of four mice (18-20 g) were injected intramuscularly in the right gastrocnemius with 15 g of venom in 50 l of PBS. This dose was selected because it induces prominent myonecrosis in mice. 20 Antivenoms (0.2 ml) were administered intravenously at either 0, 30, 60, or 120 min after envenomation. Control mice were injected with either 15 g of venom or PBS. Three hours after venom injection, blood samples were collected from the tail into heparinized capillary tubes, and plasma creatine kinase (CK) activity was determined using Sigma kit 520. The CK activity was expressed as units/milliliter, with one unit resulting in the phosphorylation of one nanomole of creatine/min at 25ЊC.
Quantification of antibodies in tissue. To analyze antibody distribution in muscle tissue, groups of four mice (18-20 g) were injected intramuscularly in the right gastrocnemius with 15 g of M. nigrocinctus venom in 50 l of PBS. Control animals received 50 l of PBS alone. At different time intervals, 0.2 ml of either IgG or F(abЈ) 2 antivenoms were then administered intravenously. One hour after injection of venom or PBS, mice were killed and both gastroc-nemius muscles were dissected out. Muscles were weighed and homogenized in 2.0 ml of PBS containing 2% bovine serum albumin. Homogenates were centrifuged, and the concentration of horse antibodies in the supernatants was estimated by an ELISA. Briefly, plates were coated with 100 l (10 g/ml) of a M. nigrocinctus venom solution. After a washing step, 100 l of homogenate supernatant were added. A standard curve was also constructed by adding known volumes of either IgG or F(abЈ) 2 antivenoms. After a 1-hr incubation, plates were washed and an anti-equine IgG conjugated with alkaline phosphatase was added. Plates were incubated, washed, and p-nitrophenyl phosphate substrate was added. Absorbances were recorded at 405 nm. After estimating the antibody concentration/mg of muscle tissue (nl of antivenom/mg of muscle), results were presented as the percentage increment of antibody concentration when compared with the concentration in contralateral, non-injected gastrocnemius muscles.
Statistical analysis. Significant differences between the mean values of two experimental groups was determined by the Student's t-test.
RESULTS

Neutralization of lethality.
Antivenoms were adjusted to similar ED 50 s when tested in preincubation-type experiments. The ED 50 s for IgG and F(abЈ) 2 antivenoms with 95% confidence intervals were 610 g of venom/ml of antivenom (423-880) and 610 g of venom/ml of antivenom (442-842), respectively. In another set of experiments, mice were injected intraperitoneally with 2 LD 50 s of venom and at different time intervals received various doses of antivenom by the intravenous route. Results indicate that the sooner antivenom was injected, the higher its neutralizing activity, as shown by lower ED 50 s (l of antivenom required to protect 50% of the envenomated mice). When antivenom administration was delayed 30 or 60 min, lethality was still evident. No significant differences were observed in ED 50 s between IgG and F(abЈ) 2 antivenoms when administered at 0, 10, 20, 30, and 60 min after envenomation ( Table 1 ).
The mean Ϯ SEM time of death among four mice receiving 40 g of venom (4 LD 50 s) and no antivenom was 79 Ϯ 8 min. When subneutralizing doses of antivenoms were administered immediately after venom injection, F(abЈ) 2 was * Mice were injected intraperitoneally with 40 g venom (corresponding to 4 median lethal doses) and then, either immediately or after 30 min, various volumes of antivenom were administered intravenously. The time of death (min) was recorded. Mice injected with venom and no antivenom died at 79 Ϯ 8 min (n ϭ 4). Results are presented as mean Ϯ SEM (n ϭ 4).
† P Ͻ 0.05 when compared with time of death in mice treated with IgG. No significant differences between IgG-and F(abЈ) 2 -treated mice were observed at the other doses and times. Time of death was significantly prolonged in mice treated with F(abЈ) 2 immediately after envenomation when compared with animals receiving venom and no antivenom. more effective than IgG at prolonging the time of death (Table 2) in experiments where 100 l of antivenom was administered. At doses of 50 and 25 l of antivenom, no significant differences were detected between antivenoms. Moreover, only animals treated with 100 l of F(abЈ) 2 antivenom immediately after envenomation showed a significant delay in the time of death in comparison with mice injected with venom alone ( Table 2) .
Reversal of ␣-neurotoxin binding. Both IgG and F(abЈ) 2 preparations were able to partially reverse, in a dose-dependent fashion, the binding of M. nigrocinctus ␣-neurotoxins to AchR (Figure 1) . At the highest concentration tested (4 M), IgG was more effective than F(abЈ) 2 , but no significant differences were observed at lower concentrations.
Neutralization of myotoxicity. In agreement with the results of previous studies, [20] [21] [22] M. nigrocinctus venom induced prominent myonecrosis after an intramuscular injection in mice. Plasma CK activity in venom-injected mice increased to 2,279 Ϯ 296 U/ml (mean Ϯ SEM), whereas the activity among PBS-treated mice was 45 Ϯ 8 U/ml. Very good neutralization was achieved by both antivenoms when administered immediately after envenomation ( Figure 2 ). However, neutralization decreased as the delay in antivenom administration increased, i.e., very poor neutralization was achieved when antivenom was administered at 60 and 120 min. No significant differences in neutralization by IgG and F(abЈ) 2 antivenoms were observed at the majority of time lapses assayed (30, 60, and 120 min), although the F(abЈ) 2 preparation was slightly more effective than IgG antivenom when administered immediately after envenomation ( Figure  2) .
Quantification of venom-specific antibodies in muscle tissue. The mean Ϯ SEM amount of venom-specific antibodies in gastrocnemius muscle of mice 1 hr after receiving an intravenous dose of 0.2 ml of IgG or F(abЈ) 2 antivenoms was 1.58 Ϯ 0.41 nl of antivenom/mg of muscle and 1.85 Ϯ 0.56 nl of antivenom/mg of muscle for IgG and F(abЈ) 2 antivenoms, respectively. When PBS was injected in the right gastrocnemius muscle, followed by intravenous administration of antivenom, an increment of 170 Ϯ 50% (mean Ϯ SEM, n ϭ 4) in the amount of antibodies was observed in the PBS-injected gastrocnemius when compared with con-tralateral, non-injected muscle. A significant increment in antibody concentration in muscle tissue was observed when mice received an intravenous dose of antivenom immediately and 20 min after an intramuscular injection of M. nigrocinctus venom (Figure 3 ). The F(abЈ) 2 fragments diffused to FIGURE 3 . Increments of IgG or F(abЈ) 2 concentration in muscle tissue after injection of Micrurus nigrocinctus venom. Mice were injected intramuscularly (right gastrocnemius) with 15 g of venom, and at various time intervals (immediately, 20 min and 40 min) 0.2 ml of either IgG or F(abЈ) 2 antivenoms were administered intravenously. One hour after envenomation, mice were killed, and both gastrocnemius muscles were dissected out, weighed, and homogenized. Antibody concentration in the homogenate supernatants were determined by ELISA (see Materials and Methods). Results (mean Ϯ SEM, n ϭ 4) are presented as % increment in antibody concentrations in the injected gastrocnemius muscle when compared with the left, non-injected gastrocnemius muscle. *P Ͻ 0.05 when compared with the antibody increment in phosphate-buffered saline (PBS)-treated mice; **P Ͻ 0.05 when comparing IgG and F(abЈ) 2 . a larger extent than IgG antibodies into muscle tissue when antivenoms were administered 20 min after envenomation (Figure 3 ). No significant increment in tissue antibody concentration was observed when antivenoms were injected 40 min after venom when compared with antibody concentrations in muscle injected with PBS ( Figure 3 ).
DISCUSSION
Micrurus venoms induce a neurotoxic effect due to the predominant action of ␣-neurotoxins that strongly bind to the AchR at the motor endplate. 13, 23 In addition, there is evidence of presynaptic activity in some coral snake venoms, such as those of M. corallinus 24 and M. nigrocinctus. 23 Besides neurotoxicity, Micrurus venoms induce myotoxicity experimentally in mice. 21, 22 From the pharmacokinetic standpoint, it has been shown that short chain neurotoxins are rapidly absorbed and distributed throughout tissues, reaching pharmacologically relevant targets relatively fast. 16 This complicates antivenom treatment, since antibody molecules have lower volumes of distribution and thus reach tissue compartments at a slower rate than neurotoxins. 16, 25 We have tested the hypothesis that due to their smaller size, F(abЈ) 2 fragments would be more efficient than IgG in the neutralization of M. nigrocinctus neurotoxins when administered after envenomation.
To test this hypothesis, and to adequately compare two antivenoms, it is important to ensure that the products have similar neutralizing efficacy in experiments with preincubation of venom and antivenoms. In these conditions, any difference detected in experiments with independent administration of venom and antivenoms (rescue experiments 16 ) would depend mainly on the pharmacokinetic characteristics of the products and not on the concentration nor the avidity of antibodies. In our study, IgG and F(abЈ) 2 antivenoms were prepared from the same batch of hyperimmune plasma and had identical ED 50 s in preincubation-type experiments. Observations showed that the neutralizing efficacy of both antivenom preparations did not differ significantly in experiments with independent injection of venom and antivenoms when neutralization was expressed as volume of antivenom required to protect 50% of envenomated animals. Moreover, serotherapy was inefficient when administered more than 30 min after venom injection, corroborating the need of a rapid antivenom treatment. On the other hand, when serotherapy was performed immediately after envenomation, F(abЈ) 2 antivenom was more efficient than IgG in prolonging the time of death when a subneutralizing antivenom dose was administered. Ismail and others 16 described a higher efficacy of F(abЈ) 2 antivenom when compared with IgG and Fab antivenoms in neutralizing Haemachatus haemachatus venom in this type of experiment. Thus, different results may be obtained when studying different venom-antivenom systems, and our conclusions cannot be extrapolated to other venoms and antivenoms.
Previous studies demonstrated the ability of antibodies to reverse the binding of elapid neurotoxins to AchR, 19, 26, 27 an observation that may have clinical implications when antivenoms are administered after the onset of muscle paralysis. Therefore, it was of interest to compare IgG and F(abЈ) 2 antibodies in this regard. Both preparations were similarly effective in partially reversing neurotoxin binding to AchR, although significantly higher reversal rates were observed with IgG at the highest concentration. In agreement with previous observations by Alape-Girón and others, 19 reversal of neurotoxin binding by antivenoms was only partial. Since these results are based on in vitro experiments, the significance of reversing neurotoxin binding in the treatment of Micrurus envenomations cannot yet be conclusively established.
No conspicuous differences were observed between the antivenoms concerning their ability to neutralize myotoxicity. In agreement with the results of Gutiérrez and others, 20 antivenoms were effective only when administered immediately after envenomation, and this is probably due to the rapid action of M. nigrocinctus myotoxins on muscle cells. 22, 28 Quantification of antibodies in muscle tissue by ELISA indicates that an intramuscular injection of venom drastically increases the extravasation of both IgG and F(abЈ) 2 . Therefore, it is likely that increased capillary permeability due to the inflammatory action characteristic of Micrurus venoms 29 was responsible for significant diffusion of antibodies to tissue and thus allowed for better neutralization of myotoxins if administered soon after envenomation. These results demonstrate the importance of studying the pharmacokinetics of antivenoms in envenomated animals, in addition to normal animals, to detect changes promoted by the action of venom components in the microvasculature that would affect antibody distribution.
The similar neutralizing ability observed for these antivenoms, despite well-demonstrated pharmacokinetic variations between F(abЈ) 2 and IgG antivenoms, 16, 25 may be due to the fact that once neurotoxins bind AchR on motor endplates, neutralization is probably very poor, despite observations of partial reversal of toxin binding in vitro. In these circumstances, higher diffusion of F(abЈ) 2 fragments to tissues does not necessarily result in improved neutralization once the toxins are bound to their target. In agreement with this, no neutralization of lethality was achieved by either antivenom when administered 30 min after venom injection. It is likely that antibodies neutralize neurotoxins mainly in the vascular compartment. Thus, the intravenous administration of an adequate volume of antivenom soon after envenomation is of particular relevance in the treatment of Micrurus bites to ensure antibody binding to toxins in the circulation and to favor a redistribution of toxins from the tissues to the vascular compartment. 25, 30 In conclusion, despite the observation that F(abЈ) 2 was more efficient than IgG in prolonging the time of death when subneutralizing doses were administered immediately after envenomation, these antivenoms had similar capabilities in neutralizing lethality and myotoxicity induced by M. nigrocinctus venom, as well as a similar ability to reverse neurotoxin binding to AchR. These observations corroborate the importance of an early intravenous administration of an adequate volume of antivenom, and stress the relevance of comparing IgG, F(abЈ) 2 and Fab antivenoms not only from the pharmacokinetic viewpoint, but also by studying neutralization of relevant pharmacologic activities of venoms.
